No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder

J Child Adolesc Psychopharmacol. 2015 May;25(4):372-5. doi: 10.1089/cap.2014.0142. Epub 2015 Apr 28.

Authors

Myriam Harfterkamp¹, Dennis van der Meer, Gigi van der Loo-Neus, Jan K Buitelaar, Ruud B Minderaa, Pieter J Hoekstra

Affiliation

¹ 1 Department of Psychiatry, University of Groningen , University Medical Center Groningen, Groningen, The Netherlands .

PMID: 25919900
DOI: 10.1089/cap.2014.0142

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adrenergic Uptake Inhibitors / therapeutic use*
Atomoxetine Hydrochloride / therapeutic use*
Attention Deficit Disorder with Hyperactivity / drug therapy*
Autism Spectrum Disorder / complications*
Child
Female
Humans
Male

Substances

Adrenergic Uptake Inhibitors
Atomoxetine Hydrochloride